Carmen Behrens

54.5k citations

169 papers · 9.5k indexed · 1 hit paper · h-index 57

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies

Papers in

Cancer Research 57
- Cancer Genomics and Diagnostics 29
- Cancer-related molecular mechanisms research 15
Oncology 71
- Cancer Immunotherapy and Biomarkers 19

Co-authors: Ignacio I. Wistuba John D. Minna Adi F. Gazdar J. Jack Lee César A. Moran Luisa M. Solis Luc Girard Waun Ki Hong
Journals: Clinical Cancer Research (27 papers)Cancer Research (21 papers)Journal of Thoracic Oncology (16 papers)Journal of Clinical Oncology (11 papers)Oncotarget (6 papers)
Partner nations: United States China Netherlands

In The Last Decade

Carmen Behrens

162 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma 2016 · 349 citations

Peers

Countries citing papers authored by Carmen Behrens

Since Specialization

Citations

This map shows the geographic impact of Carmen Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Behrens more than expected).

Fields of papers citing papers by Carmen Behrens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Behrens. The network helps show where Carmen Behrens may publish in the future.

Co-authors

The 25 scholars most cited alongside Carmen Behrens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carmen Behrens Line = papers co-authored together Carmen Behrens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients Clinical Cancer Research ·Edwin R. Parra, Carmen Behrens, Jaime Rodriguez‐Canales, Heather Lin, Barbara Mino, Jorge Blando, Jianjun Zhang, Don L. Gibbons, John V. Heymach, Boris Sepesi, Stephen G. Swisher, Annikka Weissferdt, Neda Kalhor, Julie Izzo, Humam Kadara, César A. Moran, J. Jack Lee, Ignacio I. Wistuba	2016	103
2	PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis Cancer Research ·Xiaorong Zhou, Barrett L. Updegraff, Yabin Guo, Michael Peyton, Luc Girard, Jill E. Larsen, Xian‐Jin Xie, K. De Vis, Tae Hyun Hwang, Yang Xie, Jaime Rodriguez‐Canales, Pamela Villalobos, Carmen Behrens, Ignacio I. Wistuba, John D. Minna, Kathryn A. O’Donnell	2016	56
3	IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer Cancer Research ·Mauricio S. Caetano, Huiyuan Zhang, Amber M. Cumpian, Lei Gong, Neşe Ünver, Edwin J. Ostrin, Edmund Chada Baracat, Seon Hee Chang, Cesar E. Ochoa, Samir Hanash, Carmen Behrens, Ignacio I. Wistuba, Cinthya Sternberg, Humam Kadara, Carlos Gil Ferreira, Stephanie S. Watowich, Seyed Javad Moghaddam	2016	169
4	Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations Cancer Research ·Erick Riquelme, Carmen Behrens, Heather Lin, George R. Simon, Vassiliki A. Papadimitrakopoulou, Julie Izzo, César A. Moran, Neda Kalhor, J. Jack Lee, John D. Minna, Ignacio I. Wistuba	2015	85
5	An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2 Clinical Cancer Research ·Robert J. Cardnell, Carmen Behrens, Lixia Diao, You-Hong Fan, Ximing Tang, Pan Tong, John D. Minna, Gordon B. Mills, John V. Heymach, Ignacio I. Wistuba, Jing Wang, Lauren A. Byers	2015	37
6	Radiation-Enhanced Lung Cancer Progression in a Transgenic Mouse Model of Lung Cancer Is Predictive of Outcomes in Human Lung and Breast Cancer Clinical Cancer Research ·Oliver Delgado, Kimberly Batten, James A. Richardson, Mat Hussin Yunan, Adi F. Gazdar, 付晓莉 FU Xiaoli, Luc Girard, Carmen Behrens, Milind Suraokar, E. R. Cross, Woodring E. Wright, Michael D. Story, Ignacio I. Wistuba, John D. Minna, Jerry W. Shay	2014	23
7	ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer Clinical Cancer Research ·Mohamed Kabbout, Melinda Garcia, Junya Fujimoto, Diane D. Liu, Denise M. Woods, Chi‐Wan Chow, Gabriela Mendoza, Amin A. Momin, Brian P. James, Luisa M. Solis, Carmen Behrens, J. Jack Lee, Ignacio I. Wistuba, Humam Kadara	2013	116
8	RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas Cancer Discovery ·Georgia Konstantinidou, Giorgio Ramadori, Francesca Torti, Kim Kangasniemi, Hidefumi Yosmi, Yiran Cai, Carmen Behrens, Michael T. Dellinger, Rolf A. Brekken, Ignacio I. Wistuba, Adriana Heguy, Julie Teruya‐Feldstein, Pier Paolo Scaglioni	2013	91
9	Prediction of Survival in Resected Non–Small Cell Lung Cancer Using a Protein Expression–Based Risk Model: Implications for Personalized Chemoprevention and Therapy Clinical Cancer Research ·Kathryn A. Gold, Edward S. Kim, Diane D. Liu, Ping Yuan, Carmen Behrens, Luisa M. Solis, Humam Kadara, David C. Rice, Ignacio I. Wistuba, Stephen G. Swisher, Wayne L. Hofstetter, J. Jack Lee, Waun Ki Hong	2013	27
10	Identification of a Subset of Human Non–Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma Clinical Cancer Research ·Marie Cumberbatch, Ximing Tang, Garry Beran, Евгения Кумачева, Xin Wang, Rebecca Ellston, Simon Dearden, Sabina Cosulich, Paul D. Smith, Carmen Behrens, Edward S. Kim, Xinying Su, Shuqiong Fan, Neil Gray, David P. Blowers, Ignacio I. Wistuba, Chris Womack	2013	22
11	Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling Cancer Prevention Research ·Humam Kadara, Li Shen, Junya Fujimoto, Pierre Saintigny, Chi‐Wan Chow, Wenhua Lang, Ajay Kumar M, Melinda Garcia, Mohamed Kabbout, You-Hong Fan, Carmen Behrens, Hiroki Furuhashi, Li Mao, J. Jack Lee, Kathryn A. Gold, Jing Wang, Kevin R. Coombes, Edward S. Kim, Waun Ki Hong, Ignacio I. Wistuba	2012	26
12	Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis Clinical Cancer Research ·Ximing Tang, Humam Kadara, Carmen Behrens, Diane D. Liu, Yun Xiao, David C. Rice, Adi F. Gazdar, Junya Fujimoto, César A. Moran, Marileila Varella‐Garcia, J. Jack Lee, Waun Ki Hong, Ignacio I. Wistuba	2011	59
13	Differential Impacts of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) in Epithelial IGF-Induced Lung Cancer Development Endocrinology ·Woo‐Young Kim, Mi-Jung Kim, Hojin Moon, Ping Yuan, Jin‐Soo Kim, Jong Kyu Woo, Guangcheng Zhang, Young‐Ah Suh, Lei Feng, Carmen Behrens, Carolyn S. Van Pelt, Hyunseok Kang, J. Jack Lee, Scott W. Rieder, Ignacio I. Wistuba, Ho‐Young Lee	2011	19
14	Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients Clinical Cancer Research ·Yang Xie, Guanghua Xiao, Kevin R. Coombes, Carmen Behrens, Luisa M. Solis, Gabriela Raso, Luc Girard, Heidi S. Erickson, Jack A. Roth, John V. Heymach, César A. Moran, K. D. Danenberg, John D. Minna, Ignacio I. Wistuba	2011	130
15	Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy Cancer Research ·Fei Yang, Ximing Tang, Erick Riquelme, Carmen Behrens, Monique B. Nilsson, Uma Giri, Marileila Varella‐Garcia, Lauren A. Byers, Heather Lin, Jing Wang, Maria Gabriela Raso, Luc Girard, Kevin R. Coombes, J. Jack Lee, Roy S. Herbst, John D. Minna, John V. Heymach, Ignacio I. Wistuba	2011	51
16	Aldehyde Dehydrogenase Activity Selects for Lung Adenocarcinoma Stem Cells Dependent on Notch Signaling Cancer Research ·James P. Sullivan, Monica Spinola, Michael Dodge, Maria Gabriela Raso, Carmen Behrens, Boning Gao, Katja Schuster, Chunli Shao, Jill E. Larsen, Laura A. Sullivan, Sofia Honorio, Yang Xie, Pier Paolo Scaglioni, J. Michael DiMaio, Adi F. Gazdar, Jerry W. Shay, Ignacio I. Wistuba, John D. Minna	2010	334
17	A Five-Gene and Corresponding Protein Signature for Stage-I Lung Adenocarcinoma Prognosis Clinical Cancer Research ·Humam Kadara, Carmen Behrens, Ping Yuan, Luisa M. Solis, Diane Liu, Xuemin Gu, John D. Minna, J. Jack Lee, Edward Kim, Scott W. Rieder, Ignacio I. Wistuba, Reuben Lotan	2010	68
18	Elevated Epithelial Insulin-like Growth Factor Expression Is a Risk Factor for Lung Cancer Development Cancer Research ·Woo-Young Kim, Quanri Jin, Amulya Yalamanchili, Edward S. Kim, Cristopher P Mill, Dong Hoon Lee, Lei Feng, Carmen Behrens, Ludmila Prudkin, York E. Miller, J. Jack Lee, Scott M. Lippman, Waun Ki Hong, Ignacio I. Wistuba, Ho‐Young Lee	2009	60
19	Identification of Gene Signatures and Molecular Markers for Human Lung Cancer Prognosis using an In vitro Lung Carcinogenesis System Cancer Prevention Research ·Humam Kadara, Ludovic Lacroix, Carmen Behrens, Luisa M. Solis, Xuemin Gu, J. Jack Lee, E Tahara, Dafna Lotan, Waun Ki Hong, Ignacio I. Wistuba, Reuben Lotan	2009	49
20	Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer Clinical Cancer Research ·Ludmila Prudkin, Carmen Behrens, Diane D. Liu, Dee Harrison-Findik, Natalie Ozburn, B. Nebiyou Bekele, John D. Minna, César A. Moran, Jack A. Roth, Lin Ji, Ignacio I. Wistuba	2008	68

About Carmen Behrens

Carmen Behrens is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 169 papers that have together received 9.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (58 papers), Cancer Genomics and Diagnostics (29 papers), RNA modifications and cancer (29 papers), Lung Cancer Diagnosis and Treatment (20 papers), Cancer Immunotherapy and Biomarkers (19 papers), Genetic factors in colorectal cancer (15 papers), Cancer-related molecular mechanisms research (15 papers) and Radiomics and Machine Learning in Medical Imaging (14 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (3.9k citations), Pulmonary and Respiratory Medicine (3.0k citations), Molecular Biology (5.2k citations) and Immunology (1.1k citations). Carmen Behrens has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Ignacio I. Wistuba, John D. Minna, Adi F. Gazdar, J. Jack Lee, César A. Moran, Luisa M. Solis, Luc Girard, Waun Ki Hong, Sara Milchgrub and Humam Kadara. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Journal of Thoracic Oncology, Journal of Clinical Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact